Department of Nuclear Medicine, Fudan University Shanghai Cancer Center.
Center for Biomedical Imaging.
Nucl Med Commun. 2022 Jan 1;43(1):100-107. doi: 10.1097/MNM.0000000000001478.
Microvascular invasion (MVI) is very important in the evaluation of hepatocellular carcinoma (HCC), but diagnosis is determined by postoperative pathology; thus, preoperative noninvasive methods will play an active role. The purpose of the study was to assess the performance of metabolic parameters of preoperative 18F-fluorodeoxyglucose PET/computerized tomography (18F-FDG PET/CT) in the prediction of MVI and postoperative recurrence in primary hepatocellular carcinoma.
We retrospectively collected 72 patients with HCC who have performed 18F-FDG PET/CT scan before partial hepatectomy between 2016 and 2019. We used both normal liver tissue and inferior vena cava as the reference background and combined with clinicopathological features, 18F-FDG PET/CT metabolic and volumetric indices to predict MVI and postoperative recurrence of primary HCC before surgery.
Twenty-one of the 72 patients recurred, in recurrent cases showed higher maximum standard uptake value (SUVmax), TNR (ratio of tumor SUVmax to mean SUV [SUVmean] of the background tissue), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) than nonrecurrence cases (P < 0.001). All 18F-FDG PET metabolic and volumetric indices for predicting postoperative HCC recurrence were significant on receiver-operating-characteristic (ROC) curve analyses (P < 0.05). TNRIVC, TNRNL, MTVIVC, MTVNL TLGIVC and TLGNL were significant factors for predicting MVI in HCC (P < 0.05). On multivariate analyses, MVI, SUVmax, TNRIVC, TNRNL, MTVIVC, MTVNL, TLGIVC and TLGNL (P < 0.05) are independent risk factors for predicting postoperative HCC recurrence. TNRIVC is the most relevant PET/CT parameter for predicting MVI in HCC, and MTVIVC is the most valuable for predicting postoperative HCC recurrence. Moreover, the PET/CT parameters are more accurate for prognosis with inferior vena cava as a reference background than with normal liver tissue.
18F-FDG PET/CT metabolic and volumetric indices are effective predictors, and could noninvasively provide more comprehensive predictive information on MVI and postoperative recurrence of primary HCC before surgery.
微血管侵犯(MVI)在肝细胞癌(HCC)的评估中非常重要,但诊断取决于术后病理;因此,术前非侵入性方法将发挥积极作用。本研究的目的是评估术前 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)的代谢参数在预测原发性肝细胞癌 MVI 和术后复发中的性能。
我们回顾性收集了 2016 年至 2019 年间行部分肝切除术的 72 例 HCC 患者的资料。我们使用正常肝组织和下腔静脉作为参考背景,并结合临床病理特征、18F-FDG PET/CT 代谢和容积指标,预测术前原发性 HCC 的 MVI 和术后复发。
72 例患者中有 21 例复发,复发患者的最大标准摄取值(SUVmax)、肿瘤与背景组织平均 SUV(SUVmean)比值(TNR)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)均高于未复发患者(P<0.001)。18F-FDG PET 代谢和容积指标预测 HCC 术后复发的 ROC 曲线分析均有统计学意义(P<0.05)。TNRIVC、TNRNL、MTVIVC、MTVNL、TLGIVC 和 TLGNL 是 HCC 中预测 MVI 的显著因素(P<0.05)。多因素分析显示,MVI、SUVmax、TNRIVC、TNRNL、MTVIVC、MTVNL、TLGIVC 和 TLGNL(P<0.05)是预测 HCC 术后复发的独立危险因素。TNRIVC 是预测 HCC 中 MVI 最相关的 PET/CT 参数,MTVIVC 是预测 HCC 术后复发最有价值的参数。此外,以腔静脉作为参考背景的 PET/CT 参数比以正常肝组织作为参考背景的参数对预后的预测更准确。
18F-FDG PET/CT 代谢和容积参数是有效的预测指标,可在术前非侵入性地提供更全面的原发性 HCC 微血管侵犯和术后复发预测信息。